Treatments for androgenetic alopecia and alopecia areata: Current options and future prospects

Drugs

Volumn 61, Issue 1, 2001, Pages 53-69

  Meidan, V M ^a   Touitou, E ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHAMOMILE; CORTICOSTEROID; DIPHENCYPRONE; DITHRANOL; FINASTERIDE; MINOXIDIL;

ALOPECIA AREATA; AUTOIMMUNITY; CLINICAL TRIAL; CONFOCAL LASER MICROSCOPY; DRUG EFFICACY; GENE THERAPY; GROWTH STIMULATION; HAIR GROWTH; HUMAN; IMMUNOHISTOCHEMISTRY; MALE TYPE ALOPECIA; NONHUMAN; PHOTOCHEMOTHERAPY; PUVA; REVIEW; SCALP HAIR;

EID: 0035136704     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200161010-00006     Document Type: Review

References (95)

1. Hair apparent
2. Androgenetic alopecia
3. Balding hair follicle dermal papilla cells contain higher levels of androgen receptors than those from non-balding scalp
4. Different levels of 5α-reductase type 1 and 2, aromatase, and androgen receptor in hair follicles of men and women with androgenetic alopecia
5. Testosterone metabolism in the skin: A review of its function in androgenetic alopecia, acne vulgaris, and idiopathic hirsutism including recent studies with antiandrogens
6. Alopecia areata: Pathogenesis and clinical picture
7. Alopecia areata and cytomegalovims infection in twins: Genes versus environment?
8. Update on hair disorders: Topical immunotherapy in alopecia areata
9. Autoimmune hair loss (alopeeia areata) transferred by T-lymphocytes to human scalp explants on SCID mice
10. Effects of hypertrichotic agents on follicular and nonfollicular cells in vitro
11. Activation of cytoprotective prostaglandin synthesase-1 by minoxidil as a possible explanation for its hair growth-stimulating effect
12. Hair regrowth: Therapeutic agents
13. Minoxidil sulfate effect on internal calcium of cell in the epidermis and epidermal appendages
14. Minoxidil upregulates the expression of vascular endothelial growth factor in human hair dermal papilla cells
15. Whole follicular culture
16. Macaque and rodent models for the screening of drugs for stimulating hair growth
17. Chemical agents and peptides affect hair growth
18. Topical minoxidil therapy in hereditary androgenetic alopecia
19. Topical minoxidil in early male pattern baldness
20. Rogaine (topical minoxidil) in the management of male-pattern baldness and alopecia areata: Summary
21. Quantitative estimation of hair growth: Comparative changes in weight and hair count with 5% and 2% minoxidil, placebo and no treatment
22. Ketoconazole shampoo: Effect of long-term use in androgenic alopecia
23. Safety and efficacy of topical minoxidil in the management of androgenetic atopecia
24. Long-term follow-up of men with male pattern baldness treated with topical minoxidil
25. Five year follow-up of men with androgenetic alopecia treated with topical minoxidil
26. Dose response study of topical minoxidil in male pattern alopecia
27. Bioavailability assessment of topical delivery systems effect of vehicle evaporation upon in vitro delivery of minoxidil from solution formulations
28. Effect of minoxidil concentration on the deposition of drug and vehicle into the skin
29. Absorption of minoxidil after topical application: Effect of frequency and site of application
30. Relationship between contact time of applied dose and percutaneous absorption of minoxidil from a topical solution
31. Quantitative Evaluation of topical 5% minoxidil in the treatment of diffuse androgen-dependent alopecia in females
32. Androgenetic alopecia in the female: Treatment with 2% topical minoxidil solution
33. Minoxidil: Update on its clinical role
34. Safety of long term therapy with 3% and 5% topical minoxidil in female androgenetic alopecia
35. The effect of finasteride, a 5αreductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness
36. Clinical studies on the effects of oral finasteride, a type II 5α-reductase inhibitor, on scalp hair in men with male pattern baldness
37. Finasteride in the treatment of men with androgenetic alopecia: Finasteride Male Pattern Hair Loss Study Group
38. Relationship between follicular nerve supply and alopecia
39. Endothelial localization of substance P (SP) in innervated and non-innervated blood vessels in the scalp skin of patients with scalp burning, pain and hair loss
40. Follicular penetration
41. Topical liposome delivery of molecules to hair follicles in mice
42. Evaluation of dioxalane derivatives as percutaneous absorption enhancers for topical minoxidil
43. The effects of finasteride in men with frontal male pattern hair loss
44. Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: An in vivo study using the hamster ear model
45. Topical finasteride in the treatment of androgenic alopecia: Preliminary evaluations after a 16-month therapy course
46. 5α-reductase inhibitors: A new hope in dermatology?
47. Hair tonics
48. Treatment of androgenetic alopecia with a 7.5% herbal preparation
49. Topical minoxidil solution in the treatment of alopecia areata
50. Treatment of alopecia areata
51. Alopecia areata
52. Assay of 0.2% fluocinolone acetonide cream for alopecia areata and totalis
53. Alopecia areata
54. Glucocorticoid regulation of hair growth in alopecia areata
55. Prednisotone therapy for alopecia areata: A follow-up report
56. PUVA treatment for alopecia areata: Does it work? A retrospective view of 102 cases
57. PUVA treatment of alopecia areata, partialis totalis and universalis: Audit of 10 years experience at St Johns Institute
58. Evaluation of anthralin in the treatment of alopecia areata
59. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone: Evaluation of 68 cases
60. Inhibition of a Langerhans cell-mediated immune response by treatment modairies useful in psoriasis
61. New treatments for alopecia areata
62. Treatment-resistant alopecia areata response to combination therapy with minoxidil plus anthralin
63. Alopecia areata: Current therapy
64. Pilot study to evaluate the effect of topical betamethasone dipropionate on the percutaneous absorption of minoxidil from 5% topical solution
65. The treatment of alopecia areata
66. Label-retaining cells reside in the bulge area of pilosebaceous unit: Implications for follicular stem cells, hair cycle, and skin carcinogenesis
67. Hair shaft elongation, follicle growth and spontaneous regression in long-term, sponge-gel supported histoculture of human scalp skin
68. Topical liposome targeting of dyes, melanins, genes, and proteins selectively to hair follicles
69. Radiation sensitivity of human hair follicles in SCID-hu mice
70. Quantitative models for the study of hair growth in vivo
71. The effects of finasteride (proscar) on hair growth, hair cycle stage, and serum testosterone and dihydrotestosterone in adult male and female stumptail macaques
72. Localization of lipophilic molecules penetration into rat skin by quantitative autoradiography
73. Quantitative skin autoradiography: An efficient tool in measuring drug localized in skin layers, hair follicles and glands
74. Methods for the quantitation of drugs in the skin
75. Modulation of caffeine skin delivery by carrier design: Liposomes versus penetration enhancers
76. Innervation and vasculature of the normal and alopecia areata (AA) scalp hair follicle: Absence of a neuronal marker on blood vessels associated with the lower third of the follicle
77. Localization of gamma-interferon (IFN-Gamma) expression to the precortical matrix and inner root sheath of hair-follicles in normal controls and patients with alopecia-areata
78. A miniaturised fibre optic confocal endoscope for in vivo subsurface microscopy
79. Fibre optic confocal imaging (FOCI) of keratinocytes, blood vessels and nerves in hairless mouse skin in vivo
80. The penetration enhancer SEPA™ augments stimulation of scalp hair growth by topical minoxidil in the balding stumptail macaque
81. Targeted delivery to the pilosebaceous unit via liposomes
82. The influence of skin surface lipids on topical formulations
83. Ethosomes - Novel vesicular carriers: Characterization and delivery properties
84. Novel approaches for delivery of drugs into and across the skin
85. Liposomes can specifically target entrapped melanin to hair follicles in histocultured skin
86. Model of selective gene therapy of hair growth: Liposome targeting of the active lac-Z gene to hair follicles of histocultured skin
87. Topical tretinoin for hair growth promotion
88. Hair growth effects of oral administration of finasteride, a steroid 5α-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque
89. Improvement in androgenetic alopecia (stage V) using topical minoxidil in a retinoid vehicle and oral finasteride
90. Improvement in the inflammatory aspect of androgenetic alopecia: A pilot study with an antimicrobial lotion
91. Topical FK506: A potent immunotherapy for alopecia areata? Studies using the Dundee experimental bald rat model
92. Pulse steroid therapy for children's severe alopecia areata
93. RU58841 a new therapeutic agent affecting androgen receptor molecular interactions in human hair follicles
94. Universalis associated with a mutation in the human hairless gene
95. Efficient delivery of transgenes to human hair follicle progenitor cells using topical lipoplex